Novavax (NVAX) Stock Price & Financial Analysis
Novavax Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Novavax
What is the current stock price for NVAX?
As of the latest trading session, NVAX stock trades at $8.93. The 52-week range is $5.87–$11.97, with a day range of $8.71–$9.33.
What is the P/E ratio for NVAX?
Novavax's trailing P/E ratio is 3.6, meaning investors pay $3.6 for every $1 of annual earnings. Novavax operates in the Healthcare sector.
Does NVAX pay dividends?
Novavax does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NVAX?
Based on 1 analyst, the consensus for NVAX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NVAX?
Novavax's market capitalization is $1.55B, classifying it as a small-cap company. Novavax operates in the Healthcare sector within the Biotechnology industry.